| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jie Wu | |
| Hongyan Zhou | |||
| Miaomiao Bi | |||
| Wensong Zhang | |||
| P2860 | cites work | [Split-cornea transplantation - a novel concept to reduce corneal donor shortage] | Q84061855 |
| Role of senescent fibroblasts on alkali-induced corneal neovascularization | Q84090726 | ||
| Mesenchymal stem cells improve healing of the cornea after alkali injury | Q85195995 | ||
| PPAR-γ agonist pioglitazone affects rat gouty arthritis by regulating cytokines | Q85229274 | ||
| Effects of topical chondrocyte-derived extracellular matrix treatment on corneal wound healing, following an alkali burn injury | Q85836140 | ||
| Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats | Q86088848 | ||
| Pro-inflammatory cytokines correlate with classical risk factors for atherosclerosis in the admixed Brazilian older women | Q86130546 | ||
| Activated skin γδ T-cells regulate T-cell infiltration of the wound site after burn | Q87075106 | ||
| The effect of TC14012 on alkali burn-induced corneal neovascularization in mice | Q87933203 | ||
| Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway | Q88216217 | ||
| Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone | Q95608429 | ||
| Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats. | Q48365312 | ||
| β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway | Q48576353 | ||
| Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs | Q48601590 | ||
| Effects of the matrix metalloproteinase inhibitor GM6001 on the destruction and alteration of epithelial basement membrane during the healing of post-alkali burn in rabbit cornea | Q48708769 | ||
| Suberoylanilide hydroxamic acid (vorinostat): its role on equine corneal fibrosis and matrix metalloproteinase activity | Q50222951 | ||
| Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. | Q50495247 | ||
| Long-term management of severe ocular surface injury due to methamphetamine production accidents. | Q50588884 | ||
| Visual Acuity Outcomes of the Boston Keratoprosthesis Type 1: Multicenter Study Results. | Q51652951 | ||
| Expression of matrix metalloproteinases (MMP)-12 by myofibroblasts during alkali-burned corneal wound healing. | Q51775677 | ||
| Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. | Q51980102 | ||
| Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation. | Q52812058 | ||
| Pharmacokinetics of topically applied recombinant human keratinocyte growth factor-2 in alkali-burned and intact rabbit eye. | Q53231426 | ||
| Amniotic membrane transplantation with and without limbal stem cell transplantation in chemical eye injury. | Q53234843 | ||
| Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization. | Q53285395 | ||
| Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma. | Q53467381 | ||
| The Immune Response to Skin Trauma Is Dependent on the Etiology of Injury in a Mouse Model of Burn and Excision. | Q53563100 | ||
| Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization. | Q53615409 | ||
| Inhibition of RAP1 enhances corneal recovery following alkali injury. | Q53648815 | ||
| MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ. | Q53651758 | ||
| Tenuigenin Prevents IL-1β-induced Inflammation in Human Osteoarthritis Chondrocytes by Suppressing PI3K/AKT/NF-κB Signaling Pathway. | Q54216741 | ||
| Protein phosphatase magnesium dependent 1A governs the wound healing-inflammation-angiogenesis cross talk on injury. | Q54324494 | ||
| Regulation of peroxisome proliferator-activated receptor β/δ expression and activity levels by toll-like receptor agonists and MAP kinase inhibitors in rat astrocytes. | Q54354423 | ||
| Astragalin inhibits IL-1β-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-κB and MAPK activation. | Q55068320 | ||
| Pseudolaric acid B inhibits T-cell mediated immune response in vivo via p38MAPK signal cascades and PPARγ activation. | Q55069346 | ||
| Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications | Q57244278 | ||
| Chemically injured keratocytes induce cytokine release by human peripheral mononuclear cells | Q58336798 | ||
| Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice | Q64377071 | ||
| An inhibitor of the matrix metalloproteinase synthesized by rabbit corneal epithelium | Q68257111 | ||
| Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea | Q73537304 | ||
| Functional genomics of PPAR-gamma in human immunomodulatory cells | Q83191710 | ||
| Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy | Q26773103 | ||
| Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells | Q26774850 | ||
| Corneal blindness and xenotransplantation | Q26852558 | ||
| Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases | Q27022548 | ||
| Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-γ Expression | Q27302829 | ||
| Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor | Q28295759 | ||
| Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo | Q28371943 | ||
| Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice | Q28391341 | ||
| Polysaccharide hydrogel combined with mesenchymal stem cells promotes the healing of corneal alkali burn in rats | Q28544711 | ||
| Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth | Q33411968 | ||
| The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease | Q33600282 | ||
| An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer | Q33690773 | ||
| Pretranscriptional regulation of Tgf-beta1 by PI polyamide prevents scarring and accelerates wound healing of the cornea after exposure to alkali | Q33731237 | ||
| Minocycline inhibits alkali burn-induced corneal neovascularization in mice | Q34359185 | ||
| NK1 receptor antagonists as a new treatment for corneal neovascularization. | Q34439056 | ||
| Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface | Q34452923 | ||
| Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter | Q34568504 | ||
| Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea. | Q34881192 | ||
| Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity | Q35086161 | ||
| Omental transposition in treatment of severe ocular surface alkaline burn: an experimental study | Q35138288 | ||
| Keratocytes create stromal spaces to promote corneal neovascularization via MMP13 expression | Q35239226 | ||
| Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture | Q35660853 | ||
| Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation | Q35665181 | ||
| Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency | Q35745399 | ||
| Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation | Q35874254 | ||
| Macrophage PPARγ and impaired wound healing in type 2 diabetes | Q35875469 | ||
| Burn enhances toll-like receptor induced responses by circulating leukocytes | Q35929590 | ||
| A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction. | Q35975412 | ||
| Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts | Q36005992 | ||
| Efficacy of the nucleotide-binding oligomerzation domain 1 inhibitor Nodinhibit-1 on corneal alkali burns in rats | Q36243072 | ||
| Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization | Q40235961 | ||
| PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-γ to increase surface FasL. | Q40373354 | ||
| Hypoxia-reoxygenation enhances interleukin-8 production from U937 human monocytic cells. | Q40456724 | ||
| PPAR-γ agonist attenuates inflammation in aortic aneurysm patients | Q40693751 | ||
| Ketorolac eye drops reduce inflammation and delay re-epithelization in response to corneal alkali burn in rabbits, without affecting iNOS or MMP-9. | Q41256280 | ||
| Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model | Q41454864 | ||
| Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice | Q41636642 | ||
| Toll like receptors gene expression of human keratinocytes cultured of severe burn injury. | Q41686419 | ||
| PPAR-γ activation by Tityus serrulatus venom regulates lipid body formation and lipid mediator production | Q41754457 | ||
| An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model | Q41828038 | ||
| Peroxisome proliferator activated receptor gamma loaded dental implant improves osteogenesis of rat mandible | Q42210244 | ||
| Cytokine expression in the alkali-burned cornea | Q42441159 | ||
| Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases | Q42458820 | ||
| Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report | Q42563919 | ||
| Aloe vera gel facilitates re-epithelialization of corneal alkali burn in normal and diabetic rats | Q43192113 | ||
| Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. | Q43940001 | ||
| Injury primes the innate immune system for enhanced Toll-like receptor reactivity | Q44002949 | ||
| Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury | Q44301453 | ||
| KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization. | Q45097252 | ||
| Rosiglitazone, a PPAR-gamma ligand, reduces burn progression in rats. | Q46059381 | ||
| Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing | Q46259318 | ||
| Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: the effect on Toll-like receptor signaling pathways | Q46356442 | ||
| Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells | Q46444352 | ||
| Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation | Q46630524 | ||
| Allograft survival enhancement using doxycycline in alkali-burned mouse corneas | Q46844083 | ||
| Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice | Q46951016 | ||
| Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist | Q47755433 | ||
| TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds | Q47842516 | ||
| Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists | Q48257894 | ||
| A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis | Q36283368 | ||
| PPARs in diseases: control mechanisms of inflammation | Q36353852 | ||
| Development of a novel in vivo corneal fibrosis model in the dog. | Q36386152 | ||
| Trauma-induced heterotopic bone formation and the role of the immune system: A review | Q36395829 | ||
| PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. | Q36458927 | ||
| Diospyros kaki Extract Inhibits Alkali Burn-Induced Corneal Neovascularization | Q36475902 | ||
| Recognition and signaling by toll-like receptors. | Q36527707 | ||
| Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. | Q36571709 | ||
| PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines | Q36605155 | ||
| PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies | Q36676571 | ||
| Differential Effects of Dexamethasone and Doxycycline on Inflammation and MMP Production in Murine Alkali-Burned Corneas Associated with Dry Eye. | Q36829083 | ||
| Perturbed mononuclear phagocyte system in severely burned and septic patients | Q37074014 | ||
| TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. | Q37315298 | ||
| G-CSF drives a posttraumatic immune program that protects the host from infection | Q37620301 | ||
| A Review of the Local Pathophysiologic Bases of Burn Wound Progression | Q37812096 | ||
| Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy | Q37817830 | ||
| Early and late complications of ocular burn injuries | Q38281309 | ||
| Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders. | Q38288519 | ||
| Physical and chemical injuries to eyes and eyelids | Q38364118 | ||
| Barrier function in the ocular surface: from conventional paradigms to new opportunities | Q38424509 | ||
| Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging | Q38469591 | ||
| Protective effect of soft contact lenses after Boston keratoprosthesis. | Q38567172 | ||
| Limbal transplantation at a tertiary hospital in Brazil: a retrospective study | Q38587805 | ||
| Macrophage polarization: the link between inflammation and related diseases | Q38607431 | ||
| Skin dendritic cells in burn patients. | Q38639933 | ||
| Assessment of therapeutic options for reducing alkali burn-induced corneal neovascularization and inflammation. | Q38664180 | ||
| Simvastatin attenuates angiotensin II‑induced inflammation and oxidative stress in human mesangial cells | Q38942368 | ||
| Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. | Q38988747 | ||
| Large lamellar corneoscleral grafts: tectonic role in initial management of severe ocular chemical injuries | Q38991864 | ||
| Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis | Q38993564 | ||
| Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins | Q39019411 | ||
| Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs | Q39648558 | ||
| Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand | Q39708256 | ||
| Antifibrotic effect by activation of peroxisome proliferator-activated receptor-gamma in corneal fibroblasts | Q39771067 | ||
| Successful management of severe unilateral chemical burns in children using simple limbal epithelial transplantation (SLET). | Q40173919 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intracellular receptor | Q117980 |
| chemical eye injury | Q5090456 | ||
| sensory nervous system | Q11101 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1003-1011 | |
| P577 | publication date | 2016-08-04 | |
| 2016-10-01 | |||
| P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
| P1476 | title | The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review) | |
| P478 | volume | 38 |
| Q49953571 | The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation. | cites work | P2860 |
Search more.